Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06879522 · ClinicalTrials.gov registry record · NA
Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors
A NA study of Breast Cancer Survivor and Cancer-related Fatigue, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06879522: Active NA study of Breast Cancer Survivor and Cancer-related Fatigue, sponsored by University of Pittsburgh.
NCT06879522 is a NA study of Breast Cancer Survivor and Cancer-related Fatigue that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 96-participant average among 5 other Breast Cancer Survivor trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06879522, a NA study of Breast Cancer Survivor and Cancer-related Fatigue, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing a program called Maximizing Energy to see if it can help women who have finished breast cancer treatment manage their fatigue. The study has two main goals: 1. Check if the program can be successfully delivered - Researchers will see if women are willing to join and stay in the study, if they follow the program, and if they find it helpful. 2. See if the program works - Researchers will compare Maximizing Energy to a general health education program to see which one helps reduce cancer-related fatigue better. Participant will: 1. Take tests to see if they qualify and to measure their fatigue. 2. Be randomized to receive Maximizing Energy or Health Education Interventions for 6 sessions over the internet 3. After the sessions and again one month later, repeat some tests to see if their fatigue has improved.
Primary Outcome
The proportion of participants who remain in the study until its completion relative to those initially enrolled. The retention rate will be calculated separately for the Maximizing Energy and Control Groups using the following formula: (number of participants who completed the study/number of participants initially enrolled)X 100
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Maximizing Energy Intervention
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
What the registry record for NCT06879522 still lists
NCT06879522 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 96-participant average among 5 other Breast Cancer Survivor trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Breast Cancer Survivor appearing as the primary indexed condition, and to 2 interventions - of which Health Education is the first listed.
NCT06879522 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06879522 about?
NCT06879522 is a clinical study titled "Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors". This study is testing a program called Maximizing Energy to see if it can help women who have finished breast cancer treatment manage their fatigue. The study has two main goals: 1. Check if the program can be successfully delivered - Researchers will see if women are willing to join and stay in th...
What is the current status of trial NCT06879522?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-05-14. Estimated completion is 2026-03-15.
What conditions does trial NCT06879522 study?
This clinical trial studies the following conditions: Breast Cancer Survivor, Cancer-related Fatigue.
What interventions are being tested in trial NCT06879522?
The interventions under investigation include: Health Education (BEHAVIORAL), Maximizing Energy Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06879522?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06879522 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
RECRUITING · NA
-
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer
RECRUITING · NA
-
Group Interventions for Breast Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
mHealth for Breast Cancer Survivors With Insomnia
COMPLETED · NA
-
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI